Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regulus Therapeutics Inc | RGLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.26 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.26 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.08 - 3.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 2.26 | USD |
Regulus Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 45.7M | 20.22M | - | 0 | -30.04M | -1.49 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regulus Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.44 | 2.60 | 2.09 | 2.24 | 189,916 | -0.18 | -7.38% |
| 1 Month | 2.88 | 2.9999 | 2.09 | 2.68 | 390,755 | -0.62 | -21.53% |
| 3 Months | 1.22 | 3.78 | 1.1609 | 2.38 | 3,323,101 | 1.04 | 85.25% |
| 6 Months | 1.22 | 3.78 | 1.08 | 2.37 | 1,555,003 | 1.04 | 85.25% |
| 1 Year | 1.32 | 3.78 | 1.08 | 2.35 | 793,531 | 0.94 | 71.21% |
| 3 Years | 1.40 | 3.78 | 0.1576 | 1.10 | 1,129,604 | 0.86 | 61.43% |
| 5 Years | 1.12 | 3.78 | 0.1576 | 1.13 | 1,125,070 | 1.14 | 101.79% |
Regulus Therapeutics Description
| Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. |
